David A. Ricks
David A. Ricks's purchase track record
How the stock did after each of David A. Ricks's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/25/2026 | ADBE | $1.95M | +23.5% | pending | — |
| 8/12/2025 | LLY | $1.05M | +54.9% | +60.9% | +7.7% |
| 1/28/2025 | ADBE | $999K | -16.2% | -16.3% | +5.0% |
| 9/27/2022 | ADBE | $337K | +20.7% | +34.5% | +8.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Eli Lilly gets EMA backing for Foundayo obesity pill. The European Medicines Agency panel issued a positive opinion on Lilly's Foundayo pill for obesity and type 2 diabetes, clearing a regulatory hurdle for the drug. Recent coverage also notes Lilly's broader pipeline beyond Zepbound and rising competitive pressure on Novo Nordisk. In parallel, the company's largest shareholder announced a $347 million stock sale, adding another layer of market interest.
Transaction History
| ADBE | ▲ Buy | Open Market | 10,000 | $1.9M | 6/25/2026 | View on chart |
| ADBE | ▲ Buy | Option Exercise | 900 | $0 | 4/15/2026 | View on chart |
| LLY | ▲ Buy | Grant | 38,914 | $40.7M | 2/9/2026 | View on chart |
| LLY | ▲ Buy | Option Exercise | 31,932 | $0 | 2/1/2026 | View on chart |
| LLY | ▼ Sell | Tax Withholding | 14,297 | $14.8M | 2/1/2026 | View on chart |
| LLY | ▼ Sell | Gift | 24,750 | $0 | 11/10/2025 | View on chart |
| LLY | ▲ Buy | Open Market | 1,632 | $1.1M | 8/12/2025 | View on chart |
| ADBE | ▲ Buy | Option Exercise | 633 | $0 | 4/22/2025 | View on chart |
| LLY | ▲ Buy | Grant | 55,132 | $47.9M | 2/10/2025 | View on chart |
| LLY | ▲ Buy | Option Exercise | 26,561 | $0 | 2/1/2025 | View on chart |
| LLY | ▼ Sell | Tax Withholding | 11,903 | $9.7M | 2/1/2025 | View on chart |
| ADBE | ▲ Buy | Open Market | 2,250 | $999K | 1/28/2025 | View on chart |
| LLY | ▼ Sell | Gift | 13,727 | $0 | 8/20/2024 | View on chart |
| ADBE | ▲ Buy | Option Exercise | 836 | $0 | 4/17/2024 | View on chart |
| LLY | ▲ Buy | Grant | 38,392 | $28.3M | 2/12/2024 | View on chart |
| LLY | ▼ Sell | Gift | 956 | $0 | 2/8/2024 | View on chart |
| LLY | ▲ Buy | Option Exercise | 29,611 | $0 | 2/1/2024 | View on chart |
| LLY | ▼ Sell | Tax Withholding | 13,240 | $8.5M | 2/1/2024 | View on chart |
| LLY | ▼ Sell | Gift | 15,000 | $0 | 11/14/2023 | View on chart |
| LLY | ▼ Sell | Gift | 9,550 | $0 | 8/9/2023 | View on chart |
| ADBE | ▲ Buy | Option Exercise | 672 | $0 | 4/20/2023 | View on chart |
| LLY | ▲ Buy | Grant | 56,208 | $19.4M | 2/10/2023 | View on chart |
| LLY | ▼ Sell | Gift | 4,200 | $0 | 2/8/2023 | View on chart |
| LLY | ▲ Buy | Option Exercise | 47,786 | $0 | 2/1/2023 | View on chart |
| LLY | ▼ Sell | Tax Withholding | 21,359 | $7.4M | 2/1/2023 | View on chart |
| ADBE | ▲ Buy | Open Market | 1,200 | $337K | 9/27/2022 | View on chart |
| ADBE | ▲ Buy | Option Exercise | 615 | $0 | 4/14/2022 | View on chart |
| LLY | ▲ Buy | Grant | 68,004 | $16.5M | 2/9/2022 | View on chart |
| LLY | ▲ Buy | Option Exercise | 56,205 | $0 | 2/1/2022 | View on chart |
| LLY | ▼ Sell | Tax Withholding | 25,170 | $6.2M | 2/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
ADBE Shares Fall as AI Software Competition Heats Up
Adobe shares have fallen more than the broader market recently, with analysts questioning whether it can keep pace with AI-driven rivals like Salesforce. News coverage has focused on how Adobe stacks up against competitors in the software industry and whether its cash position justifies its valuation. The stock is trading well below its 52-week high of $363.70, and technical signals show it is testing key support near $237.67.
ADBE Shares Fall as AI Software Competition Heats Up. Adobe shares have fallen more than the broader market recently, with analysts questioning whether it can keep pace with AI-driven rivals like Salesforce. News coverage has focused on how Adobe stacks up against competitors in the software industry and whether its cash position justifies its valuation. The stock is trading well below its 52-week high of $363.70, and technical signals show it is testing key support near $237.67.